Discovery and development of novel antibiotics to treat multidrug-resistant infections.
About Josephine SchrøderThis author has not yet filled in any details.
So far Josephine Schrøder has created 6 blog entries.
Specialized in fusion molecules based on secondary metabolites from eukaryotes.
Developing game-changing alternatives to fossil-based plastics
Developing first-in-class therapeutics for novel intervention of disabling skin conditions
Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis
Developing diagnostic self-tests